Southport Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $544K | Sell |
10,505
-116,037
| -92% | -$6.02M | 0.2% | 128 |
|
|
2021
Q4 | $7.47M | Buy |
126,542
+105,132
| +491% | +$5.21M | 1.31% | 15 |
|
|
2021
Q3 | $921K | Sell |
21,410
-38,647
| -64% | -$1.71M | 0.37% | 81 |
|
|
2021
Q2 | $2.35M | Buy |
60,057
+66
| +0.1% | +$2.57K | 0.58% | 49 |
|
|
2021
Q1 | $2.17M | Buy |
59,991
+20,531
| +52% | +$729K | 0.57% | 48 |
|
|
2020
Q4 | $1.45M | Sell |
39,460
-1,408
| -3% | -$51.6K | 0.52% | 60 |
|
|
2020
Q3 | $1.42M | Sell |
40,868
-2,349
| -5% | -$82.4K | 0.54% | 56 |
|
|
2020
Q2 | $1.34M | Buy |
43,217
+3,320
| +8% | +$113K | 0.57% | 59 |
|
|
2020
Q1 | $1.24M | Buy |
39,897
+462
| +1% | +$15.7K | 0.65% | 50 |
|
|
2019
Q4 | $1.47M | Sell |
39,435
-3,277
| -8% | -$117K | 0.57% | 57 |
|
|
2019
Q3 | $1.46M | Buy |
42,712
+3,999
| +10% | +$145K | 0.66% | 44 |
|
|
2019
Q2 | $1.59M | Buy |
38,713
+248
| +0.6% | +$9.85K | 0.72% | 43 |
|
|
2019
Q1 | $1.55M | Buy |
38,465
+60
| +0.2% | +$2.4K | 0.69% | 48 |
|
|
2018
Q4 | $1.59M | Buy |
38,405
+34
| +0.1% | +$1.41K | 0.8% | 36 |
|
|
2018
Q3 | $1.6M | Buy |
38,371
+1,572
| +4% | +$60.5K | 0.68% | 41 |
|
|
2018
Q2 | $1.27M | Sell |
36,799
-272
| -0.7% | -$9.29K | 0.57% | 59 |
|
|
2018
Q1 | $1.25M | Buy |
37,071
+1,343
| +4% | +$46.2K | 0.56% | 63 |
|
|
2017
Q4 | $1.23M | Buy |
35,728
+499
| +1% | +$17K | 0.47% | 71 |
|
|
2017
Q3 | $1.19M | Buy |
35,229
+18
| +0.1% | +$579 | 0.51% | 69 |
|
|
2017
Q2 | $1.12M | Buy |
35,211
+388
| +1% | +$12.2K | 0.49% | 70 |
|
|
2017
Q1 | $1.13M | Sell |
34,823
-336
| -1% | -$10.6K | 0.64% | 55 |
|
|
2016
Q4 | $1.08M | Buy |
35,159
+932
| +3% | +$28.5K | 0.66% | 51 |
|
|
2016
Q3 | $1.1M | Sell |
34,227
-4,475
| -12% | -$150K | 0.77% | 44 |
|
|
2016
Q2 | $1.29M | Sell |
38,702
-1,940
| -5% | -$61.9K | 0.72% | 40 |
|
|
2016
Q1 | $1.14M | Buy |
40,642
+37
| +0.1% | +$1.06K | 0.73% | 46 |
|
|
2015
Q4 | $1.24M | Sell |
40,605
-51
| -0.1% | -$1.6K | 0.8% | 43 |
|
|
2015
Q3 | $1.21M | Buy |
40,656
+424
| +1% | +$13.6K | 0.81% | 42 |
|
|
2015
Q2 | $1.28M | Sell |
40,232
-5,691
| -12% | -$185K | 0.77% | 44 |
|
|
2015
Q1 | $1.52M | Sell |
45,923
-6,428
| -12% | -$204K | 0.9% | 37 |
|
|
2014
Q4 | $1.55M | Buy |
52,351
+3,843
| +8% | +$110K | 0.93% | 35 |
|
|
2014
Q3 | $1.36M | Buy |
48,508
+4,845
| +11% | +$136K | 0.9% | 38 |
|
|
2014
Q2 | $1.23M | Buy |
43,663
+240
| +0.6% | +$6.84K | 0.82% | 43 |
|
|
2014
Q1 | $1.32M | Hold |
43,423
| – | – | 0.93% | 36 |
|
|
2013
Q4 | $1.26M | Sell |
43,423
-2,424
| -5% | -$70.5K | 0.89% | 37 |
|
|
2013
Q3 | $1.25M | Buy |
45,847
+106
| +0.2% | +$2.88K | 0.97% | 33 |
|
|
2013
Q2 | $1.22M | Buy |
+45,741
| New | +$1.26M | 0.99% | 32 |
|
Other funds holding PFE
Southport Capital Management's PFE Position: Q1 2022 in Review
Southport Capital Management reduced its Pfizer (PFE) stake by 92% in Q1 2022, selling an estimated $6.02M and leaving 10,505 shares worth $544K. The position accounts for 0.2% of the portfolio, ranked #128.
Southport Capital Management first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $7.47M in Q4 2021. 3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Southport Capital Management held 10,505 shares of Pfizer worth $544K as of Q1 2022.
- Southport Capital Management sold 116,037 Pfizer shares in Q1 2022, an estimated $6.02M.
- Pfizer made up 0.2% of Southport Capital Management's portfolio in Q1 2022, its #128 holding.
- Southport Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- Southport Capital Management's Pfizer position peaked at $7.47M in Q4 2021.
- 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.